NanoLithium NP03

lithium nanoparticle formulation NP03 · Medesis Pharma SA

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NanoLithium NP03, covering 2025-01-17 to 2025-01-17. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Safety and Efficacy Evaluation of NanoLithium® NP03 in Patients With Mild-to-severe Alzheimer's Disease [Phase 2]

See pricing